Immunohistochemical analysis of P53 and bcl-2 in benign and malignant salivary glands tumors

Journal of Oral Pathology and Medicine

Volumn 39, Issue 1, 2010, Pages 48-55

  Al Rawi, Natheer H ^a   Omer, Husam ^b   Al Kawas, Sausan ^a  

^a UNIVERSITY OF SHARJAH   (United Arab Emirates)

^b UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Apoptosis; Bcl 2; Immunohistochemistry; P53; Salivary gland tumors

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; SALIVARY GLAND TUMOR; TUMOR VOLUME;

ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; ADOLESCENT; ADULT; AGED; CARCINOMA; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; CELL COUNT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, MULTIPLE PRIMARY; PROTO-ONCOGENE PROTEINS C-BCL-2; SALIVARY GLAND NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 76249095366     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00816.x     Document Type: Article

References (42)

1. Cawson R, Odell E. Neoplastic and non-neoplastic diseases of salivary glands: salivary glands neoplasms. In : Cawson R, Odell E, Porter S, eds. Essential of oral pathology and oral medicine, 6th edn. Hong Kong Churchill Livingstone an imprint of Elsevier Science, 2003 247 256.
2. Lievo I, Jee K, Kinheimok H, et al. Characterization of gene expression in major types of salivary glands carcinomas with epithelial differentiation. Cancer Gen Cytogen 2005 156 : 104 113.
3. EL-Naggar A, Abdul-Karim F, Hurr K, Callender D, Luna M, Batsakis G. Genetic alterations in acinic cell carcinoma of the parotid gland determined by microsatellite analysis. Cancer Gen Cytogen 1998 102 : 19 24.
4. Borowska KB, Filip A, Wojcierowski J, et al. Estimation of prognostic value of Bcl-α L gene expression in non-small cell lung cancer. Lung Cancer 2006 51 : 61 9.
5. 53B tumor suppressor gene in adenoid cystic carcinoma and mucoepidermoid carcinoma of the salivary glands. Oral Oncol 2001 73 : 315 322.
6. Cui R, Widlund HR, Feige E, et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007 128 : 853 864.
7. 53B expression, stage and histological features in endometrial cancer. Eur J Obst Gynecol & Reprod Biol 2005 125 : 111 116.
8. 53B and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients. Oral Oncol 2000 36 : 54 60.
9. Deguchi H, Hamano H, Hayash Y. C myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of human salivary glands. Acta Pathol Jpn 1993 43 : 413 422.
10. Li X, Tsuji T, Wen S, Sobhan F, Wang Z, Shinozaki F. Cytoplasmic expression of p53 protein and its morphological features in salivary gland lesions. J Oral Pathol Med 1994 24 : 201 205.
11. CostaRoza J, Felix A, Fonseca I, Soares J. Immunoexpression of c-erbb-2 and p53 in benign and malignant salivary gland neoplasms with myoepithelial differentiation. J Clin Pathol 1997 50 : 661 668.
12. Nordvist A, Roijer E, Bang G, et al. Expression and mutation patterns of p53 in benign and malignant salivary gland tumors. Int J Oncol 2000 16 : 477 483.
13. Ohtake S, Cheng J, Ida H, et al. Precancerous foci of pleomorphic adenoma of salivary glands: recognition of focal cancer and atypical tumor cells by p53 immunohistochemistry. J Oral Pathol Med 2002 31 : 590 597.
14. Yanez M, Roa I, Garcia M, Ibacache G, Villaseca M. bcl-2 gene expression in salivary gland tumors. Rev Med Chil 1999 127 : 139 142.
15. 53B, bcl-2 and Ki-67 expression in adenoid cystic carcinoma of the palate. Clinico-pathologic studies of twenty one cases with long term follow up. Pathol Res Pract 2005 200 : 791 799.
16. Cuevas E, Bateman A, Wilkins B, et al. Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies. J Clin Pathol 1994 47 : 448 452.
17. Ohki K, Kumamoto H, Ichinohasama R, et al. Genetic analysis of DNA micro satellite loci in salivary glands tumors. Comparison with immunohistochemical detection of hMSH2 and PB53B proteins. Int J Maxillofac Surg 2001 30 : 344 358.
18. Aoki T, Tsukinoki K, Karakida K, Ota Y, Otsura M, Kaneko A. Expression of cyclo oxygenase-2, bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor differentiation & apoptosis. Oral Oncol 2004 40 : 954 959.
19. AL-Rawi NH. Intraoral salivary gland tumors: a clinicopathological analysis of 140 cases. Iraqi Dent J 2001 27 : 143 150.
20. Actis A, Lampe B, Eynard A. Cellular basis and clinical implications of biological markers in salivary tissues: their topological distribution in murine submandibular gland. Oral Oncol 2002 38 : 441 449.
21. Jia R, Esguerra X, Tang H, et al. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol Int 2004 54 : 217 223.
22. Harris C, Hollstein M. Medical progress: clinical implications of the p53 tumour suppressor gene. N Engl J Med 1993 329 : 1318 1327.
23. Alves F, Pires F, de Almeida O, Lopes M, Kowalski L. PCNA, Ki-67 and p53 expression in submandibular salivary gland tumours. Int J Oral Maxillofac Surg 2004 33 : 593 597.
24. Papadaki H, Finkelstein S, Kounelis K, Bakker A, Swalsky P, Kapadia S. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma. Hum Pathol 1996 27 : 567 572.
25. Gordón-Núñez MA, Godoy GP, Soares RC, de Souza LB, de Almeida Freitas R, Queiroz LM. Inmunohistochemical expression of PCNA, p53 and bcl-2 in pleomorphic adenomas. Int J Morphol 2008 26 : 567 572.
26. Jorge J, Pires F, Alves F, et al. Juvenile pleomorphic adenoma, report of 5 cases and review of literatures. Int J Maxillofac Surg 2002 31 : 273 275.
27. 53B in benign and malignant neoplasm with myoepithelial differentiation. J Clin Pathol 1997 50 : 661 663.
28. Perez DC, Pires FR, Alves FA, Almeida O, Kowalski L. Salivary glands tumors in children and adolescents: a clinico pathological and immunohistochemical study of fifty three cases. Int J Ped Otorhinolaryngol 2004 68 : 895 902.
29. Righis PD, Li YQ, Deutsch M, et al. The role of the p53 gene in the malignant transformation of pleomorphic adenomas of the parotid gland. Antcancer Res 1994 14 (5B 2253 2257.
30. Langauer C, Kinzler KW, Volgelstein B. Genetic instabilities in human. Nature 1998 396 : 643 649.
31. Hisaoka M, Morimitsu Y, Hashimoto H. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas. Am J Surg Pathol 1999 23 : 1480 1492.
32. Mark J, Dahlenfors R, Ekedahl C, Stenman G. The mixed salivary gland tumor - a normally benign human neoplasm frequently showing specific chromosome abnormalities. Cancer Genet Cytogenet 1980 2 : 231 241.
33. Sandros J, Stenman G, Mark J. Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet 1990 44 : 153 167.
34. Bullerdiek J, Wobst G, Meyer-Bolte K, et al. Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 1993 65 : 27 31.
35. Mark J, Dahlenfors R, Wedell B. Impact of the in vitro technique used on the cytogenetic patterns in pleomorphic adenomas. Cancer Genet Cytogenet 1997 95 : 9 15.
36. Huang SM, Schonthal AH, Stallcup MR. Enhancement of p53-dependent gene activation by the transcriptional cofactor ZAC1. Oncogene 2001 20 : 2134 2143.
37. Debiec-Rychter M, Van Valckenborgh I, Van den Broeck C, et al. Histologic localization of PLAG1 (pleomorphic adenoma gene 1) in pleomorphic adenoma of the salivary gland: cytogenetic evidence of common origin of phenotypically diverse cells. Lab Invest 2001 81 : 1289 1297.
38. Fan K, Connor S, MacBean A, Longdon J. MRI findings of carcinosarcoma in the parotid gland. Oral Oncol 2005 42 : 323 326.
39. Lewis JE, Oslen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma, pathologic analysis of 73 cases. Human Pathol 2003 32 : 596 604.
40. Xin W, Paulino AFG. Prognostic factors in malignant mixed tumors of salivary glands: correlation of immunohistochemical markers with histologic classification. Ann Diag Pathol 2002 4 : 205 210.
41. Andreadis D, Poulopoulos A, Epivatianos A, Nomikos A, Christidis K, barbatis C. Carcino-sarcoma of the parotid gland: immunohistochemical analysis with emphasis in cell cycle mitotic activity and cell adhesion molecule expression. Oral Oncol 2006 42 : 140 143.
42. Röijer E, Dahlenfors R, Mark J, Stemman G. Observations by chromosome banding, FISH and immunohistochemistry in an adenoid cystic carcinoma with del(17)(p13) as the sole deviation. Virchows Arch 1997 430 : 339 342.